StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Neuroscience — U.S. revenue by Quarter

Neuroscience — U.S. revenue ($M) ($M)

QuarterlyAnnual

Eli Lilly Neuroscience — U.S. revenue: $325M in Q2 2026, up 31.0% from a year earlier. That is the highest of the 38 quarters on record here.

Latest, Q2 2026
325
Period ended Jun 30, 2026
Change on a year earlier
+31.0%
248 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
33
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Note 2 Disaggregated Revenue.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNeuroscience — U.S. revenue ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026325+31.0%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026293+55.0%Form 10-Q (filed 2026-04-30) ↗
Q4 2025Dec 31, 2025320+43.2%Form 10-K (filed 2026-02-12) ↗
Q3 2025Sep 30, 2025240+19.0%Form 10-Q (filed 2025-10-30) ↗
Q2 2025Jun 30, 2025248+29.2%Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 2025189+15.8%Form 10-Q (filed 2026-04-30) ↗
Q4 2024Dec 31, 2024224+22.1%Form 10-K (filed 2026-02-12) ↗
Q3 2024Sep 30, 2024201-2.9%Form 10-Q (filed 2025-10-30) ↗
Q2 2024Jun 30, 2024192+19.3%Form 10-Q (filed 2025-08-07) ↗
Q1 2024Mar 31, 2024163+12.9%Form 10-Q (filed 2025-05-01) ↗
Q4 2023Dec 31, 2023183+8.8%Form 10-K (filed 2026-02-12) ↗
Q3 2023Sep 30, 2023207+42.2%Form 10-Q (filed 2024-10-30) ↗
Q2 2023Jun 30, 2023161+11.1%Form 10-Q (filed 2024-08-08) ↗
Q1 2023Mar 31, 2023145-5.8%Form 10-Q (filed 2024-04-30) ↗
Q4 2022Dec 31, 2022168+4.1%Form 10-K (filed 2025-02-19) ↗
Q3 2022Sep 30, 2022146+0.8%Form 10-Q (filed 2023-11-02) ↗

Breakdown

What makes up neuroscience — U.S. revenue

Cite this data

StockData. (2026). Eli Lilly Neuroscience — U.S. revenue ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/ta-neuroscience-us

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.